Literature DB >> 16637071

PLZF regulates Pbx1 transcription and Pbx1-HoxC8 complex leads to androgen-independent prostate cancer proliferation.

Tadahiko Kikugawa1, Yumi Kinugasa, Ken Shiraishi, Daisuke Nanba, Koh-ichi Nakashiro, Nozomu Tanji, Masayoshi Yokoyama, Shigeki Higashiyama.   

Abstract

BACKGROUND: Promyelocytic leukemia zinc finger (PLZF) protein, a transcriptional repressor and negative regulator of the cell cycle, has been characterized as a prostatic androgen-responsive gene. DU145 cells show androgen-independent growth and lack PLZF gene expression.
METHODS: We analyzed PLZF-regulating genes by DNA microarray using DU145 cells infected with LacZ- or PLZF-carrying adenoviruses.
RESULTS: DNA microarray revealed that Pbx1 is a prominent suppressed gene in PLZF-overexpressing DU145 cells. Androgen receptor (AR)-expressing DU145 cells recovered androgen-dependent PLZF expression and subsequent repression of Pbx1 expression. Immunoprecipitation of Pbx1 in DU145 cells revealed a Pbx1-HoxC8 heterocomplex. siRNAs for Pbx1 and HoxC8 knocked downexpression of each, and this suppressed androgen-independent cell growth. Double knockdown of both Pbx1 and HoxC8 suppressed cell growth much more significantly.
CONCLUSIONS: Androgen-independent cell line DU145 cells lack PLZF gene expression, resulting in the upregulation of Pbx1 and HoxC8 expression. The Pbx1-HoxC8 heterocomplex may lead to androgen-independent growth in prostate cancer. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16637071     DOI: 10.1002/pros.20443

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  27 in total

Review 1.  The Hox genes and their roles in oncogenesis.

Authors:  Nilay Shah; Saraswati Sukumar
Journal:  Nat Rev Cancer       Date:  2010-04-01       Impact factor: 60.716

2.  PBX3 promotes migration and invasion of colorectal cancer cells via activation of MAPK/ERK signaling pathway.

Authors:  Hai-Bo Han; Jin Gu; Deng-Bo Ji; Zhao-Wei Li; Yuan Zhang; Wei Zhao; Li-Min Wang; Zhi-Qian Zhang
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

Review 3.  The Estrogen Receptor α-Cistrome Beyond Breast Cancer.

Authors:  Marjolein Droog; Mark Mensink; Wilbert Zwart
Journal:  Mol Endocrinol       Date:  2016-08-04

4.  The BTB-ZF family of transcription factors: key regulators of lineage commitment and effector function development in the immune system.

Authors:  Aimee M Beaulieu; Derek B Sant'Angelo
Journal:  J Immunol       Date:  2011-09-15       Impact factor: 5.422

5.  PLZF, a tumor suppressor genetically lost in metastatic castration-resistant prostate cancer, is a mediator of resistance to androgen deprivation therapy.

Authors:  Chen-Lin Hsieh; Ginevra Botta; Shuai Gao; Tiantian Li; Eliezer M Van Allen; Daniel J Treacy; Changmeng Cai; Housheng Hansen He; Christopher J Sweeney; Myles Brown; Steven P Balk; Peter S Nelson; Levi A Garraway; Philip W Kantoff
Journal:  Cancer Res       Date:  2015-03-25       Impact factor: 12.701

6.  FoxC1 promotes epithelial-mesenchymal transition through PBX1 dependent transactivation of ZEB2 in esophageal cancer.

Authors:  Xiaoming Zhu; Li Wei; Yangqiu Bai; Sen Wu; Shuangyin Han
Journal:  Am J Cancer Res       Date:  2017-08-01       Impact factor: 6.166

7.  PLZF/ZBTB16, a glucocorticoid response gene in acute lymphoblastic leukemia, interferes with glucocorticoid-induced apoptosis.

Authors:  Muhammad Wasim; Michela Carlet; Muhammad Mansha; Richard Greil; Christian Ploner; Alexander Trockenbacher; Johannes Rainer; Reinhard Kofler
Journal:  J Steroid Biochem Mol Biol       Date:  2010-05-06       Impact factor: 4.292

8.  PBX1 is a favorable prognostic biomarker as it modulates 13-cis retinoic acid-mediated differentiation in neuroblastoma.

Authors:  Nilay Shah; Jianjun Wang; Julia Selich-Anderson; Garrett Graham; Hasan Siddiqui; Xin Li; Javed Khan; Jeffrey Toretsky
Journal:  Clin Cancer Res       Date:  2014-06-19       Impact factor: 12.531

Review 9.  Pioneer factors in hormone-dependent cancers.

Authors:  Kamila M Jozwik; Jason S Carroll
Journal:  Nat Rev Cancer       Date:  2012-05-04       Impact factor: 60.716

10.  Integrative clinical genomics of advanced prostate cancer.

Authors:  Dan Robinson; Eliezer M Van Allen; Yi-Mi Wu; Nikolaus Schultz; Robert J Lonigro; Juan-Miguel Mosquera; Bruce Montgomery; Mary-Ellen Taplin; Colin C Pritchard; Gerhardt Attard; Himisha Beltran; Wassim Abida; Robert K Bradley; Jake Vinson; Xuhong Cao; Pankaj Vats; Lakshmi P Kunju; Maha Hussain; Felix Y Feng; Scott A Tomlins; Kathleen A Cooney; David C Smith; Christine Brennan; Javed Siddiqui; Rohit Mehra; Yu Chen; Dana E Rathkopf; Michael J Morris; Stephen B Solomon; Jeremy C Durack; Victor E Reuter; Anuradha Gopalan; Jianjiong Gao; Massimo Loda; Rosina T Lis; Michaela Bowden; Stephen P Balk; Glenn Gaviola; Carrie Sougnez; Manaswi Gupta; Evan Y Yu; Elahe A Mostaghel; Heather H Cheng; Hyojeong Mulcahy; Lawrence D True; Stephen R Plymate; Heidi Dvinge; Roberta Ferraldeschi; Penny Flohr; Susana Miranda; Zafeiris Zafeiriou; Nina Tunariu; Joaquin Mateo; Raquel Perez-Lopez; Francesca Demichelis; Brian D Robinson; Marc Schiffman; David M Nanus; Scott T Tagawa; Alexandros Sigaras; Kenneth W Eng; Olivier Elemento; Andrea Sboner; Elisabeth I Heath; Howard I Scher; Kenneth J Pienta; Philip Kantoff; Johann S de Bono; Mark A Rubin; Peter S Nelson; Levi A Garraway; Charles L Sawyers; Arul M Chinnaiyan
Journal:  Cell       Date:  2015-05-21       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.